In a study in IBD patients, scientists observed shifts in gut chemistry, among other changes, that could lead to new treatment strategies.
MagGel-BS platform addresses challenges related to the targeted delivery and subsequent recovery of engineered bacteria within the GI tract.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback